Dimensional Fund Advisors
ADPT icon

Dimensional Fund Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Dimensional Fund Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Sell
31,324
-157,014
-83% -$2.41M ﹤0.01% 2932
2026
Q1 		$2.61M Sell
188,338
-1,194,586
-86% -$19M ﹤0.01% 2647
2025
Q4 		$22.5M Sell
1,382,924
-3,439
-0.2% -$56.1K ﹤0.01% 1919
2025
Q3 		$20.7M Sell
1,386,363
-3,325
-0.2% -$40.5K ﹤0.01% 1975
2025
Q2 		$16.2M Sell
1,389,688
-34,984
-2% -$318K ﹤0.01% 2067
2025
Q1 		$10.6M Sell
1,424,672
-180,204
-11% -$1.39M ﹤0.01% 2229
2024
Q4 		$9.62M Buy
1,604,876
+183,881
+13% +$1.01M ﹤0.01% 2319
2024
Q3 		$7.27M Buy
1,420,995
+51,898
+4% +$226K ﹤0.01% 2405
2024
Q2 		$4.96M Sell
1,369,097
-374,519
-21% -$1.19M ﹤0.01% 2492
2024
Q1 		$5.6M Sell
1,743,616
-394,575
-18% -$1.53M ﹤0.01% 2520
2023
Q4 		$10.5M Sell
2,138,191
-152,986
-7% -$698K ﹤0.01% 2301
2023
Q3 		$12.5M Buy
2,291,177
+141,231
+7% +$934K ﹤0.01% 2142
2023
Q2 		$14.4M Buy
2,149,946
+501,585
+30% +$3.73M ﹤0.01% 2088
2023
Q1 		$14.6M Buy
+1,648,361
New +$14.5M ﹤0.01% 2058
2022
Q3 		$4.85M Buy
681,077
+265,593
+64% +$2.5M ﹤0.01% 2437
2022
Q2 		$3.36M Sell
415,484
-47,440
-10% -$417K ﹤0.01% 2581
2022
Q1 		$6.42M Sell
462,924
-11,584
-2% -$182K ﹤0.01% 2460
2021
Q4 		$13.3M Buy
474,508
+264,902
+126% +$8.12M ﹤0.01% 2192
2021
Q3 		$7.12M Buy
209,606
+83,549
+66% +$3.02M ﹤0.01% 2464
2021
Q2 		$5.15M Sell
126,057
-8,435
-6% -$328K ﹤0.01% 2599
2021
Q1 		$5.41M Buy
134,492
+50,701
+61% +$2.74M ﹤0.01% 2552
2020
Q4 		$4.96M Buy
83,791
+70,091
+512% +$3.61M ﹤0.01% 2530
2020
Q3 		$666K Sell
13,700
-16,506
-55% -$694K ﹤0.01% 3009
2020
Q2 		$1.46M Sell
30,206
-3,517
-10% -$128K ﹤0.01% 2842
2020
Q1 		$937K Buy
+33,723
New +$941K ﹤0.01% 2917

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors's ADPT Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Adaptive Biotechnologies (ADPT) stake by 83% in Q2 2026, selling an estimated $2.41M and leaving 31,324 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Dimensional Fund Advisors first reported a position in ADPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $22.5M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Dimensional Fund Advisors held 31,324 shares of Adaptive Biotechnologies worth $672K as of Q2 2026.
  • Dimensional Fund Advisors sold 157,014 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.41M.
  • Adaptive Biotechnologies made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2932 holding.
  • Dimensional Fund Advisors first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 25 quarters since.
  • Dimensional Fund Advisors's Adaptive Biotechnologies position peaked at $22.5M in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.